Safety profile and pharmacokinetics of an inhaled GATA-3-specific DNAzyme in a phase Ib study in patients with stable allergic asthma

被引：0
|
作者：
Hohlfeld, Jens [1 ]
Lueer, Katrin [1 ]
Krug, Norbert [1 ]
Turowska, Agnieszka [2 ]
Renz, Harald [3 ]
Garn, Holger [3 ]
Homburg, Ursula [2 ]
机构：
[1] Fraunhofer ITEM, Clin Airway Res, Hannover, Germany
[2] GmbH, Sterna Biol, Marburg, Germany
[3] Univ Marburg, Clin Chem & Mol Diagnost, Marburg, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
Asthma; -; management; Pharmacology; Anti-inflammatory;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1916
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study
    Hidenori Kato
    Paul de Souza
    Sang-We Kim
    Jason D. Lickliter
    Yoichi Naito
    Keunchil Park
    Sanjeev Kumar
    Ganesh M. Mugundu
    Yung-Jue Bang
    Targeted Oncology, 2020, 15 : 75 - 84
  • [22] Phase ib study of safety, tolerability and pharmacokinetics of simotinib in patients with advanced non-small cell lung cancer
    Hu, Xingsheng
    Han, Xiaohong
    Zhang, Li
    Ding, Yanhua
    Wang, Hanping
    Mu, Hua
    Sun, Yan
    Shi, Yuankai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study
    Masuda, Norikazu
    Iwata, Hiroji
    Aogi, Kenjiro
    Xu, Yihuan
    Ibrahim, Ayman
    Gao, Ling
    Dalal, Rita
    Yoshikawa, Reigetsu
    Sasaki, Yasutsuna
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (12) : 1088 - 1094
  • [24] Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study
    Kato, Hidenori
    de Souza, Paul
    Kim, Sang-We
    Lickliter, Jason D.
    Naito, Yoichi
    Park, Keunchil
    Kumar, Sanjeev
    Mugundu, Ganesh M.
    Bang, Yung-Jue
    TARGETED ONCOLOGY, 2020, 15 (01) : 75 - 84
  • [25] A phase IIa study to evaluate the safety, pharmacodynamics and pharmacokinetics of TGN255 in stable haemodialysis patients
    Combe, Sophie
    DSouza, Richard
    Mysliwiec, Michal
    Padmanabhan, Neal
    Thomas, Mark
    Villa, Giuseppe
    Will, Eric
    Patrick, Guy
    Kennedy, Anthony
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 215 - 216
  • [26] Pooled Safety Profile Of The Tlr-9 Agonist Cyt003, From Three Phase 2 Studies Of Patients With Allergic Rhinitis Or Allergic Asthma
    Casale, T.
    Klimek, L.
    Lassen, C.
    Willers, J.
    Beeh, K. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [27] A phase Ib study of the mTOR inhibitor RAD001 (everolimus) in combination with letrozole (Femara®), investigating safety and pharmacokinetics in patients with advanced breast cancer stable or slowly progressing on letrozole
    Awada, A
    Cardoso, F
    Fontaine, C
    Dirix, L
    De Grève, J
    Sotiriou, C
    Steinseifer, J
    Wouters, C
    Tanaka, C
    Ressayre-Djaffer, C
    Piccart, M
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S234 - S235
  • [28] Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study
    Corren, Jonathan
    Ambrose, Christopher S. S.
    Griffiths, Janet M. M.
    Hellqvist, Asa
    Lindsley, Andrew W. W.
    Llanos, Jean-Pierre
    Colice, Gene
    Menzies-Gow, Andrew
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (04): : 417 - 428
  • [29] Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis
    Mclaurin, Eugene B.
    Evans, David
    Repke, Carolyn S.
    Sato, Michelle A.
    Gomes, Paul J.
    Reilly, Erin
    Blender, Nysha
    Silva, Fabiana Q.
    Vantipalli, Srilatha
    Metzinger, Jamie L.
    Gibson, Andrea
    Goldstein, Michael H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 229 : 288 - 300
  • [30] A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors
    Goh, Jeffrey
    Gao, Ben
    Markman, Ben
    Gan, Hui
    Voskoboynik, Mark
    Wu, Yi-Long
    Guo, Jun
    Zhou, Qing
    Zhao, Jun
    Chen, Cheng
    Qiu, Jingjun
    Xu, Yingying
    Yang, Liu
    Millward, Michael
    CANCER RESEARCH, 2019, 79 (13)
12345